Clinical Trial Dosing

Initiation of Treatment with TTI-101, Either Alone or in Combination with Standard Targeted Therapy, in Advanced Hepatocellular Carcinoma _ Pharmtales - Latest Pharma News & Insights

Initiation of Treatment with TTI-101, Either Alone or in Combination with Standard Targeted Therapy, in Advanced Hepatocellular Carcinoma

SG Tylor

Source – Tvardi Therapeutics On June 22, 2023 the initial administration of TTI-101, either as a monotherapy or in combination ...